Multiple Dose Japanese Bridging Study

Status:
Completed

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety and tolerability of multiple oral daily doses of BMS-708163 in healthy young male subjects

Phase 1

Bristol-Myers Squibb